The lncRNA CCAT1 Upregulates Proliferation and Invasion in Melanoma Cells via Suppressing miR-33a.

It is increasingly evident that various long noncoding RNAs (lncRNAs) participate in the tumorigenesis of multiple tumors, including melanoma. lncRNAs have been validated as oncogenic factors in various tumors; however, the potential regulatory mechanism of CCAT1 in melanoma is still unclear. The purpose of this study was to investigate the regulation of CCAT1 on melanoma genesis. The expression of CCAT1 in melanoma tissue and cell lines was measured using qRT-PCR. Interference oligonucleotide or mimic sequences were applied to up- or downregulate RNA expression. CCK-8 and colony formation assays were performed to detect the proliferation capability. Transwell assay was used to assess the migration and invasion capacities. Bioinformatics analysis was performed to predict the target miRNAs of CCAT1. Expression of CCAT1 was significantly upregulated in melanoma tissue and cell lines. CCAT1 knockdown observably suppressed the proliferation, migration, and invasion abilities. Bioinformatics analysis predicted that miR-33a acted as a target of CCAT1, which was confirmed by dual-luciferase reporter assay. CCAT1 knockdown reversed the tumor-promoting ability of the miR-33a inhibitor. CCAT1 acts as an oncogenic factor in the genesis of melanoma and exerts tumor-promoting roles via sponging miR-33a, providing a novel insight for competing endogenous RNA (ceRNA) in the tumorigenesis of melanoma.

[1]  Shan Liu,et al.  Long Noncoding RNA PVT1 as a Novel Diagnostic Biomarker and Therapeutic Target for Melanoma , 2017, BioMed research international.

[2]  Xiaoqiang Guo,et al.  CCAT1: an oncogenic long noncoding RNA in human cancers , 2017, Journal of Cancer Research and Clinical Oncology.

[3]  Xiaqing Guo,et al.  Long non-coding RNA CCAT1 promotes glioma cell proliferation via inhibiting microRNA-410. , 2016, Biochemical and biophysical research communications.

[4]  W. Peng,et al.  Long noncoding RNA CCDC26 as a potential predictor biomarker contributes to tumorigenesis in pancreatic cancer. , 2016, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

[5]  Ana Brândusa Pavel,et al.  Identifying cancer type specific oncogenes and tumor suppressors using limited size data , 2016, J. Bioinform. Comput. Biol..

[6]  Linna Guo,et al.  A novel integrative approach to identify lncRNAs associated with the survival of melanoma patients. , 2016, Gene.

[7]  P. Lim,et al.  Excision versus incision biopsy in the management of malignant melanoma* , 2016, The Journal of dermatological treatment.

[8]  P. Gao,et al.  A novel long noncoding RNA-LOWEG is low expressed in gastric cancer and acts as a tumor suppressor by inhibiting cell invasion , 2016, Journal of Cancer Research and Clinical Oncology.

[9]  Ting Liu,et al.  Overexpression of long non-coding RNA CCAT1 is a novel biomarker of poor prognosis in patients with breast cancer. , 2015, International journal of clinical and experimental pathology.

[10]  Jianda Zhou,et al.  miR-33a functions as a tumor suppressor in melanoma by targeting HIF-1α , 2015, Cancer biology & therapy.

[11]  P. Guldberg,et al.  Molecular drivers of cellular metabolic reprogramming in melanoma. , 2015, Trends in molecular medicine.

[12]  Shi-bin Yang,et al.  Long noncoding RNA CCAT1 promotes hepatocellular carcinoma progression by functioning as let-7 sponge , 2015, Journal of experimental & clinical cancer research : CR.

[13]  M. Dinger,et al.  The role of microRNAs and long non-coding RNAs in the pathology, diagnosis, and management of melanoma. , 2014, Archives of biochemistry and biophysics.

[14]  A. Craft,et al.  Socioeconomic patterning in the incidence and survival of children and young people diagnosed with malignant melanoma in northern England. , 2014, The Journal of investigative dermatology.

[15]  Dmitriy Sonkin,et al.  Tumor Suppressors Status in Cancer Cell Line Encyclopedia , 2013, Molecular oncology.

[16]  B. Su,et al.  Long Noncoding RNA HOTAIR Is Associated with Motility, Invasion, and Metastatic Potential of Metastatic Melanoma , 2013, BioMed research international.

[17]  J. Lortet-Tieulent,et al.  International trends in the incidence of malignant melanoma 1953–2008—are recent generations at higher or lower risk? , 2013, International journal of cancer.

[18]  A. Bosserhoff,et al.  Promoter-hypermethylation is causing functional relevant downregulation of methylthioadenosine phosphorylase (MTAP) expression in hepatocellular carcinoma. , 2006, Carcinogenesis.